Simulating the animal-to-human pathogen jump — reservoir circulation, exposure, cross-species infection, onward transmission, and One Health mitigation
Every zoonotic spillover begins with a pathogen already thriving somewhere else: in bats, rodents, birds, non-human primates, or livestock. A "reservoir host" is a species (or set of species) in which a pathogen persists indefinitely, often causing little or no disease in that host because of a long coevolutionary relationship. This silent, ongoing circulation is the raw material from which every future spillover event is drawn — long before any human is exposed.
A reservoir host is not simply "immune" — it typically remains infected and infectious, often for life, while suffering minimal pathology. Several ecological and immunological features enable this tolerance:
• Coevolutionary history: reservoir hosts and their pathogens have often shared an evolutionary relationship spanning thousands to millions of years, selecting for host immune tolerance rather than sterilizing immunity • Dampened inflammatory response: bats, for example, show constitutively active interferon pathways alongside dampened inflammasome activation — controlling viral replication without the tissue-damaging inflammation seen in spillover hosts • Population-level maintenance: pathogens persist not necessarily in every individual but across a population, through birth-pulse dynamics (seasonal cohorts of susceptible juveniles), migration, and periodic re-introduction • Multi-host cycles: some pathogens cycle between a primary reservoir and an intermediate amplifying host (e.g., Nipah virus: fruit bats → pigs) before ever reaching humans
The reservoir status of a species is often established only retrospectively, after serological surveys following a human outbreak. For many suspected reservoirs (e.g., Ebola virus in specific bat species), decades of active field surveillance still have not conclusively identified the exact natural host.
Mammals alone are estimated to harbor over a million undiscovered viral species, of which perhaps half may have some capacity to infect humans under the right conditions. Only a small fraction of these have ever been sampled or sequenced. Key drivers of this hidden diversity:
• High mutation rates: RNA viruses in particular (coronaviruses, influenza, paramyxoviruses) mutate rapidly, continuously generating genetic variants within a reservoir population • Reassortment and recombination: segmented viruses like influenza can swap gene segments when two strains co-infect the same host cell, rapidly generating novel combinations • Reservoir host diversity: bats alone comprise over 1,400 species — roughly one in five mammal species — each potentially harboring its own distinct viral community • Geographic and ecological breadth: reservoirs span nearly every biome, from tropical forests to peri-urban rooftops, creating a vast and largely unmonitored circulation network
Well-documented examples illustrate the diversity of reservoir circulation patterns:
• Ebola and Marburg viruses: strongly suspected bat reservoirs (fruit bats), with periodic spillover into great apes and humans via unknown intermediate contact • Nipah virus: Pteropus fruit bats shed virus in urine and saliva; pigs and date palm sap serve as amplifying/intermediate routes to humans • MERS-coronavirus: circulates broadly and largely asymptomatically in dromedary camels across the Arabian Peninsula and East Africa • SARS-CoV-1 and SARS-CoV-2 lineages: horseshoe bats harbor a diverse pool of SARS-related coronaviruses; intermediate hosts (civets, and for SARS-CoV-2 a still-debated intermediate) are hypothesized links to human spillover • Avian influenza: wild aquatic birds (ducks, geese, shorebirds) are the ancestral reservoir for nearly all influenza A subtypes, with continuous low-pathogenicity circulation
A pathogen circulating quietly in a reservoir population poses no risk to people unless there is a contact pathway bringing humans into sufficient proximity with an infectious source. Spillover risk is therefore not just a property of the pathogen — it is a product of human behavior, land use, and economic activity that determines how often, how closely, and under what conditions people and animals interact.
Contact opportunities take many forms, each with a different exposure profile:
• Hunting and butchering (bushmeat): direct contact with blood, tissue, and bodily fluids of wild animals during killing, field-dressing, and preparation — a well-documented route for Ebola, Marburg, and HIV-precursor spillovers • Live-animal markets: multiple species held in close, often stressed and immunosuppressed proximity, in unhygienic conditions with intermingled airborne, fecal-oral, and blood-contact exposure pathways — implicated in SARS-CoV-1 and avian influenza spillovers • Livestock rearing and intensive farming: proximity to poultry and swine, key amplifying hosts for influenza reassortment; occupational exposure among farmers and slaughterhouse workers • Land-use change and deforestation: forest fragmentation increases "edge habitat" where wildlife and human settlements interface, altering reservoir host ecology (e.g., fruit bat roosting shifts near Nipah virus outbreaks in Malaysia and Bangladesh) • Peri-domestic rodent contact: rodents entering homes and grain stores create fecal-contamination exposure routes for hantaviruses and arenaviruses • Ecotourism and caving: direct entry into bat roosting habitats
The 1998 Nipah virus outbreak in Malaysia was traced to intensive pig farms established adjacent to fruit orchards where Pteropus bats fed — bats dropped partially-eaten, virus-contaminated fruit into pig enclosures, amplifying the virus in pigs before it spilled over to farm workers.
A single, brief encounter with an infected animal carries some probability of exposure — but risk scales strongly with the frequency, duration, and closeness of contact:
• Dose-response relationship: higher pathogen exposure doses generally increase infection probability, so repeated or prolonged contact compounds risk • Density dependence: crowded conditions (markets, factory farms) increase both the number of potentially infected animals encountered and pathogen shedding/transmission within the animal population itself • Occupational gradients: butchers, market vendors, veterinarians, and wildlife handlers face categorically higher exposure frequency than the general population • Seasonal and behavioral amplifiers: birth pulses in bat colonies, seasonal hunting practices, and religious or cultural events involving live animals can create short windows of sharply elevated contact intensity
Global trends are systematically increasing human-animal contact intensity over time:
• Human population growth and expansion into previously undeveloped wildlife habitat • Growing global demand for animal protein, driving both wildlife harvest and intensive livestock production • Climate-driven range shifts, moving reservoir species into new geographic areas and closer to human settlements • Globalized wildlife and livestock trade networks that can move an infected animal — and its pathogens — across continents within days
These structural drivers explain why zoonotic spillover risk is not a static background hazard but one actively shaped, and increasingly elevated, by human activity.
Contact alone does not guarantee infection. For a pathogen to successfully jump species, it must be biologically capable of entering and replicating within human cells — a requirement that filters out the vast majority of animal pathogens humans are ever exposed to. This molecular compatibility, most famously receptor binding, is the narrow biological gate that spillover must pass through.
Most viruses enter cells by binding a specific surface receptor protein — and that receptor must be structurally compatible with the pathogen's binding domain:
• Coronaviruses: SARS-CoV-1 and SARS-CoV-2 spike proteins bind human ACE2 (angiotensin-converting enzyme 2); small changes in the receptor-binding domain (RBD) determine whether binding is efficient, weak, or absent entirely • Influenza: hemagglutinin (HA) preferentially binds either avian-type (α2,3-linked sialic acid, found deep in the human lower respiratory tract) or human-type (α2,6-linked sialic acid, abundant in the human upper respiratory tract) receptors — avian strains typically bind poorly to human upper-airway cells, limiting transmissibility even after infection occurs • Henipaviruses (Nipah, Hendra): bind ephrin-B2/B3 receptors, which are highly conserved across mammals — one reason these viruses can already infect a broad range of hosts including humans with minimal adaptation
Even after entry, a pathogen must successfully hijack human cellular machinery to replicate:
• Polymerase compatibility: viral replication enzymes must function efficiently with human host co-factors (e.g., influenza PB2 protein adaptation to human ANP32A) • Innate immune evasion: the pathogen must evade or suppress human-specific interferon and pattern-recognition responses; a protein perfectly tuned to suppress a bat immune response may fail against the human equivalent • Temperature adaptation: avian influenza replicates best near avian body temperature (~40–41°C); efficient replication in the cooler human upper respiratory tract (~33°C) often requires specific adaptive mutations • Proteolytic activation: some viral surface proteins require cleavage by host proteases to become infectious — availability and specificity of the right human protease is a further compatibility filter
A pathogen can be extremely well-adapted to its reservoir host and yet almost completely incapable of infecting humans — this is why the overwhelming majority of animal pathogens humans are exposed to, even repeatedly, never cause a single documented human infection.
Molecular compatibility is not fixed — it can improve through evolutionary processes occurring either in the reservoir/intermediate host or during early human infection:
• Point mutation accumulation: RNA viruses in particular can accumulate receptor-binding mutations quickly given their high mutation rates and large population sizes • Reassortment (segmented viruses): influenza gene segments can mix during co-infection of an intermediate host (e.g., pigs, which carry both avian- and human-type receptors — "mixing vessel" hosts), rapidly generating novel receptor-binding combinations • Serial passage in an intermediate/amplifying host: repeated infection cycles in a host more similar to humans (e.g., civets, pigs) can pre-adapt a pathogen before it ever reaches a person • Within-host adaptation after initial spillover: even after a first human infection, further mutation during that infection can improve human-to-human transmissibility — a process implicated in several historical pandemic emergences
A pathogen infecting one person is a fundamentally different risk category from a pathogen additionally capable of sustained transmission between people. Many zoonotic infections are "dead-end" spillovers — the infected individual cannot pass the pathogen onward, so the chain terminates with them. Only when a pathogen crosses this second threshold does an isolated case become capable of growing into a cluster, an outbreak, or a pandemic.
Epidemiologists quantify onward transmission potential using the basic reproduction number, R0 — the average number of secondary human infections caused by one infected person in a fully susceptible population:
• R0 < 1: each infection produces, on average, less than one further infection — chains of transmission shrink and self-extinguish, even if individual cases can occasionally still be severe (e.g., rabies, most avian influenza H5N1 human cases to date) • R0 ≈ 1: transmission is borderline — small clusters can occur, occasionally with superspreading events producing localized outbreaks, but sustained nationwide/global spread is unlikely without significant additional adaptation (historically the pattern for MERS-CoV and Nipah virus) • R0 > 1: each infection produces more than one further infection on average — the outbreak grows exponentially unless controlled by intervention, population immunity, or behavioral change (the regime that defines pandemic-capable pathogens)
Crucially, R0 for onward human spread is a completely separate biological property from the pathogen's ability to infect a human in the first place — a pathogen can be highly lethal to individuals yet epidemiologically self-limiting.
Highly Pathogenic Avian Influenza H5N1 has caused hundreds of confirmed human infections with a case fatality rate historically above 50% — yet it has never achieved sustained human-to-human transmission, making each human case, however severe, epidemiologically a dead end so far.
Several biological and contextual factors determine whether a spillover pathogen can chain onward between people:
• Replication site and shedding route: efficient respiratory transmission generally requires robust upper-airway replication and shedding via droplets/aerosols — a pathogen replicating deep in the lower respiratory tract or primarily in blood may infect an individual severely without transmitting easily onward • Viral load and shedding duration: higher and more prolonged shedding, especially before or around symptom onset, increases transmission opportunity • Pre-symptomatic/asymptomatic transmission capability: pathogens that transmit before the host feels ill are far harder to contain via symptom-based isolation • Environmental stability: how long the pathogen survives outside a host on surfaces or in aerosols affects indirect transmission routes • Population contact structure and behavior: dense contact networks, healthcare settings without adequate infection control, and gatherings can amplify otherwise marginal transmissibility (nosocomial clusters have driven most documented MERS-CoV chains)
The historical record includes both outcomes, illustrating how this single threshold determines the ultimate scale of a zoonotic event:
• Contained: Nipah virus (Malaysia 1998–99, recurring Bangladesh outbreaks), MERS-CoV (2012–present), most avian influenza human cases, Hendra virus — all capable of infecting and sometimes killing individual humans, but without achieving efficient, sustained chains of onward human transmission • Pandemic-capable: 1918, 1957, 1968, and 2009 influenza pandemics; SARS-CoV-2 (2019–) — each acquired, through some combination of receptor adaptation and favorable epidemiological conditions, the capacity for sustained exponential human-to-human spread
This is precisely why real-time transmissibility assessment (contact tracing, cluster investigation, genomic surveillance for adaptive mutations) is one of the highest-priority actions during any newly detected zoonotic spillover event.
Because spillover risk emerges from a chain of distinct steps — reservoir circulation, contact opportunity, molecular compatibility, and onward transmission — it can also be interrupted at multiple independent points. The "One Health" framework formalizes this: it recognizes that animal health, human health, and environmental health are interconnected, and that effective mitigation requires coordinated action across all three domains rather than a single downstream fix.
The earliest and often most cost-effective interventions target the human-animal interface directly, before any exposure occurs:
• Regulating and improving hygiene standards in live-animal markets (species separation, sanitation, reduced crowding/stress on animals) • Land-use planning that limits high-risk forest-edge encroachment and preserves buffer zones around known reservoir habitats • Safer bushmeat handling practices and protective equipment for hunters and processors, plus targeted public health messaging in high-risk regions • Biosecurity improvements on farms, especially where intermediate/amplifying hosts (pigs, poultry) are raised near wildlife or wild bird populations • Diversifying protein sources to reduce economic reliance on high-risk wildlife trade where feasible
Monitoring pathogen circulation in animal populations before spillover occurs allows earlier warning and targeted response:
• Sentinel surveillance in known reservoir species (bats, rodents, migratory waterfowl) and livestock, tracking novel pathogen detection and prevalence trends • Genomic sequencing of animal pathogens to flag mutations associated with increased human receptor compatibility or transmissibility before they reach people • Veterinary and wildlife health networks integrated with public health reporting systems, enabling rapid data sharing across sectors • Trade and market surveillance for unusual animal die-offs or illness clusters, which often precede or accompany human spillover events • International data-sharing platforms (e.g., WOAH/FAO animal disease reporting systems) that flag emerging risks across borders in near real time
The One Health approach explicitly rejects a purely reactive model. Its central premise is that the same surveillance and biosecurity investment that protects animal and ecosystem health also functions as an early-warning system for human pandemic risk — making upstream investment far cheaper than downstream pandemic response.
Even with strong upstream prevention, some spillover events will still occur — making rapid human-side detection and containment the essential final layer of defense:
• Clinical syndromic surveillance for unusual illness clusters, especially in individuals with reported animal or occupational exposure • Rapid diagnostic deployment and genomic sequencing capacity to quickly characterize a novel pathogen's transmissibility and severity • Case isolation, contact tracing, and targeted quarantine to interrupt early chains of transmission before they become self-sustaining • Risk communication and community engagement, particularly in regions with frequent human-animal contact, so that early symptoms are reported rather than concealed • Stockpiled diagnostics, protective equipment, and platform technologies (e.g., adaptable vaccine and therapeutic platforms) that can be rapidly deployed against a newly emerged pathogen
Together, these three intervention layers — contact reduction, animal surveillance, and human case detection — form a defense-in-depth system: no single layer needs to be perfect if the others are functioning, which is the practical strength of the One Health framework.